Yes. The Libre 3 systems are covered by Medicare for those who qualify^†1 with a prescription.

Medicare and other payor criteria apply. 

† Patients must meet Medicare eligibility coverage criteria.

Reference: 1. Local Coverage Determination (LCD) L33822, Glucose Monitors. Accessed August 24, 2026. https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?LCDId=33822.

Please contact a participating pharmacy^‡ or supplier^‡ for more information about out-of-pocket costs. Please note, prices vary based on pharmacy or supplier and geographical differences, and are subject to change at any time and at the sole discretion of the pharmacy or durable medical equipment (DME) supplier. If you're asked to pay more than $75 for two sensors, use this copay card^¶ to start saving. Show it to your pharmacist each time you pick up your prescription.

Abbott provides this information as a courtesy and does not guarantee payment or coverage.

Coverage and out-of-pocket costs may vary based on your individual insurance plan. Please contact your insurance provider directly to confirm your specific benefits and eligibility.

‡ Participating pharmacies are subject to change without notice. Product availability may vary by retailer.

¶ Benefits apply to FreeStyle Libre personal CGM sensors and readers. Void where prohibited by law. Abbott may modify, rescind, or revoke these benefits at any time without notice. Offer available to commercially insured and uninsured patients only. These benefits are not available to beneficiaries of Medicare, Medicaid or other federal or state healthcare programs. For Massachusetts residents, only those patients responsible for the full cost of the product may be eligible to receive these benefits. These benefits are only available at participating pharmacies, which are subject to change without notice. The actual amount a patient pays may vary.

The Libre 3 systems are covered by the Department of Veterans Affairs for those who qualify^2,3. 

Please contact your healthcare provider as a prescription is required for the Libre 3 Plus sensor and reader. Your healthcare provider may also be able to provide more information on accessing the Libre 3 system using any applicable benefits and eligibility criteria. 

Prescription Criteria³:

• When your healthcare provider prescribes the continuous glucose monitor (CGM), they must confirm and document that you have diabetes and are being treated with daily insulin.

• You will need to know:

  • How to use a CGM device.
  • About fingerstick testing for calibration, and how to evaluate “high” or “low” blood glucose results or trends based on readings and/or alarms.

• You have followed your healthcare provider’s recommendations for glucose testing and medication as directed.

• You agree to ongoing medical appointments with your healthcare provider(s) at least every 6 months.

Therapeutic CGM is provided based on the Veteran’s individual medical needs and is prescribed based upon clinician and patient shared decision making as recommended by the VA/DoD Guidelines of Management of Diabetes Mellitus in Primary Care (2023)³.

Medicare and other payor criteria may apply. Abbott provides this information as a courtesy and does not guarantee payment or coverage.

Coverage and out-of-pocket costs may vary based on your individual insurance plan. Please contact your insurance provider directly to confirm your specific benefits and eligibility.

References: 2. Data on file. Abbott Diabetes Care, Inc. 3. Department of Veterans Affairs. VA/DoD Clinical Practice Guideline for the Management of Type 2 Diabetes Mellitus: Quick Reference Guide. Accessed August 24, 2026. https://www.healthquality.va.gov/guidelines/CD/diabetes/VADOD-Diabetes-CPG-Quick-Reference-Guide_final_508.pdf.